TrialNature communications2022

Neoantigen-specific CD8 T cell responses in the peripheral blood following PD-L1 blockade might predict therapy outcome in metastatic urothelial carcinoma.

Jeppe Sejerø Holm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.